• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON UNSPECIFIED BD INTROSYTE¿ INTRODUCER; CATHETER INTRODUCER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON UNSPECIFIED BD INTROSYTE¿ INTRODUCER; CATHETER INTRODUCER Back to Search Results
Catalog Number UNKNOWN
Device Problems Break (1069); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Insufficient Information (4580)
Event Date 03/31/2022
Event Type  Injury  
Manufacturer Narrative
Unknown manufacturer: there are multiple bd locations where this unspecified bd device may have been manufactured.A catalog and lot number could not be confirmed for this incident and without this information we are unable to determine where the device was manufactured.Therefore, bd corporate headquarters in (b)(4) has been listed.And the (b)(4) fda registration number has been used for the manufacture report number.Date of event: unknown.The date received by manufacturer has been used for this field.Medical device expiration date: unknown.The customer's address is unknown.(b)(6) has been used as a default.Device manufacture date: unknown.Investigation summary: bd was unable to perform a thorough investigation as no sample, lot, or batch number were provided.Based on the available information we are not able to identify a root cause at this time.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.
 
Event Description
It was reported that 8 patients experienced bleeding, and 8 patients experienced infections after the unspecified bd introsyte¿ introducers were used on them, requiring unspecified medical intervention.Additionally, 12 introducer's sheaths did not split as intended during use.No further information was provided.The following information was provided by the initial reporter: "bleeding requiring medical intervention related to insertion of the introducer - 3.Infection (within 24-48 hours after insertion of the introducer) - 3 incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 5" "it was reported that bleeding.Incorrect/incomplete splitting & infection (within 24-48 hours after insertion of the introducer) resulted in patient or clinician injury that required medical or surgical intervention when using the bd introsyte¿ introducers." "bleeding requiring medical intervention related to insertion of the introducer - 2.Infection (within 24-48 hours after insertion of the introducer) ¿ 2 incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 4." "it was reported that bleeding.Incorrect/incomplete splitting & infection (within 24-48 hours after insertion of the introducer) resulting in patient or clinician injury that required medical or surgical intervention when using the bd introsyte¿ introducers to facilitate the placement of indwelling central venous catheters." "bleeding requiring medical intervention related to insertion of the introducer - 3.Infection (within 24-48 hours after insertion of the introducer) - 3 incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 3." "it was reported that bleeding.Incorrect/incomplete splitting & infection (within 24-48 hours after insertion of the introducer) resulted in patient or clinician injury that required medical or surgical intervention that your patients have encountered when using the bd introsyte¿ introducers to facilitate the placement of guidewires.".
 
Event Description
It was reported that 12 unspecified bd introsyte¿ introducers introducer's sheaths did not split as intended during use.No further information was provided.The following information was provided by the initial reporter: "incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 5." "incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 4." "incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 3.".
 
Manufacturer Narrative
The following fields were updated due to corrections: b.5.Describe event or problem: it was reported that 12 unspecified bd introsyte¿ introducers introducer's sheaths did not split as intended during use.No further information was provided.The following information was provided by the initial reporter: "incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 5." "incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 4"."incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 3".H.2.No.Of events summarized: 12.
 
Event Description
It was reported that 12 unspecified bd introsyte¿ introducers introducer's sheaths did not split as intended during use.No further information was provided.The following information was provided by the initial reporter: "bleeding requiring medical intervention related to insertion of the introducer - 3.Infection (within 24-48 hours after insertion of the introducer) - 3.Incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 5." "it was reported that bleeding.Incorrect/incomplete splitting & infection (within 24-48 hours after insertion of the introducer) resulted in patient or clinician injury that required medical or surgical intervention when using the bd introsyte¿ introducers." "bleeding requiring medical intervention related to insertion of the introducer.- 2.Infection (within 24-48 hours after insertion of the introducer) ¿ 2.Incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 4." "it was reported that bleeding.Incorrect/incomplete splitting & infection (within 24-48 hours after insertion of the introducer) resulting in patient or clinician injury that required medical or surgical intervention when using the bd introsyte¿ introducers to facilitate the placement of indwelling central venous catheters." "bleeding requiring medical intervention related to insertion of the introducer - 3.Infection (within 24-48 hours after insertion of the introducer) - 3.Incorrect/incomplete splitting of the introducer upon its removal, requiring the removal of the device being inserted through the introducer - 3." "it was reported that bleeding.Incorrect/incomplete splitting & infection (within 24-48 hours after insertion of the introducer) resulted in patient or clinician injury that required medical or surgical intervention that your patients have encountered when using the bd introsyte¿ introducers to facilitate the placement of guidewires.".
 
Manufacturer Narrative
The following fields were updated due to corrections: b.1.Adverse type: product problem.B.5.Describe event or problem: it was reported that the patient experienced an infection that occurred after the unspecified bd introsyte¿ introducer was used on them, and had to have medical intervention as a result.No further information was provided.B.6.Relevant tests/laboratory data: none reported.H.1.Type of reportable events: malfunction.H.6.Imdrf annex e grid: e2401.H.6.Imdrf annex f grid: f24.H.6.Imdrf annex a grid: a0401.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNSPECIFIED BD INTROSYTE¿ INTRODUCER
Type of Device
CATHETER INTRODUCER
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer (Section G)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14188192
MDR Text Key289895776
Report Number2243072-2022-00537
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
UNKNOWN
Number of Events Reported12
Summary Report (Y/N)Y
Report Source Manufacturer
Source Type Other
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 08/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/22/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-